Document Detail


Scaffold-based bone engineering by using genetically modified cells.
MedLine Citation:
PMID:  15777645     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The first generation of clinically applied tissue engineering concepts in the area of skin, cartilage and bone marrow regeneration was based on the isolation, expansion and implantation of cells from the patient's own tissue. Although successful in selective treatments, tissue engineering needs to overcome major challenges to allow widespread clinical application with predictable outcomes. One challenge is to present the cells in a matrix to the implantation site to allow the cells to survive the wound healing contraction forces, tissue remodeling in certain tissues such as bone and biomechanical loading. Hence, several tissue engineering strategies focus on the development of load-bearing scaffold/cell constructs. From a cell source point of view, bone engineers face challenges to isolate and expand cells with the highest potential to form osseous tissue along with harvesting tissue without extensive donor site morbidity. A major hurdle to tissue engineering is de-differentiation and limited ability to control cell phenotype following in vitro expansion. Due to early successes with genetic engineering, bone tissue engineers have used different strategies to genetically alter various types of mesenchymal cells to enhance the mineralization capacity of tissue-engineered scaffold/cell constructs. Although the development of multi-component scaffold/osteogenic cell constructs requires a combination of interdisciplinary research strategies, the following review is limited to describe the general aspects of bone engineering and to present overall directions of technology platforms, which include a genetic engineering component. This paper reviews the most recent work in the field and discusses the concepts developed and executed by a collaborative effort of the multi-disciplinary teams of the two authors.
Authors:
Dietmar W Hutmacher; Andres J Garcia
Related Documents :
25070355 - The intermediate expression of ccrl1 reveals novel subpopulations of medullary thymic e...
23180825 - Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph...
24435095 - From proliferation to proliferation: monocyte lineage comes full circle.
23934155 - Osteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathology.
21277025 - The human decidual nk-cell response to virus infection: what can we learn from circulat...
21570115 - Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue infl...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Gene     Volume:  347     ISSN:  0378-1119     ISO Abbreviation:  Gene     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2005-04-12     Completed Date:  2005-06-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7706761     Medline TA:  Gene     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1-10     Citation Subset:  IM    
Affiliation:
Division of Bioengineering, Faculty of Engineering, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260, Singapore. biedwh@nus.edu.sg
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bone Regeneration / genetics*,  physiology
Bone and Bones* / physiology
Calcification, Physiologic / genetics*,  physiology
Cell Differentiation / genetics,  physiology
Humans
Osteogenesis / genetics*,  physiology
Tissue Engineering* / trends

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Identification and characterization of coding single-nucleotide polymorphisms within human protocadh...
Next Document:  Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus...